| Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn KF Huybrechts, BT Bateman, K Palmsten, RJ Desai, E Patorno, ... Jama 313 (21), 2142-2151, 2015 | 291 | 2015 |
| Using real-world data to predict findings of an ongoing phase IV cardiovascular outcome trial: cardiovascular safety of linagliptin versus glimepiride E Patorno, S Schneeweiss, C Gopalakrishnan, D Martin, JM Franklin Diabetes care 42 (12), 2204-2210, 2019 | 103 | 2019 |
| Effect of a remotely delivered tailored multicomponent approach to enhance medication taking for patients with hyperlipidemia, hypertension, and diabetes: the STIC2IT cluster … NK Choudhry, T Isaac, JC Lauffenburger, C Gopalakrishnan, M Lee, ... JAMA internal medicine 178 (9), 1182-1189, 2018 | 89 | 2018 |
| Claims‐based studies of oral glucose‐lowering medications can achieve balance in critical clinical variables only observed in electronic health records E Patorno, C Gopalakrishnan, JM Franklin, KG Brodovicz, ... Diabetes, Obesity and Metabolism 20 (4), 974-984, 2018 | 75 | 2018 |
| Association of fluoroquinolones with the risk of aortic aneurysm or aortic dissection C Gopalakrishnan, K Bykov, MA Fischer, JG Connolly, JJ Gagne, ... JAMA internal medicine 180 (12), 1596-1605, 2020 | 56 | 2020 |
| Brief report: patterns and secular trends in use of immunomodulatory agents during pregnancy in women with rheumatic conditions RJ Desai, KF Huybrechts, BT Bateman, S Hernandez‐Diaz, H Mogun, ... Arthritis & Rheumatology 68 (5), 1183-1189, 2016 | 47 | 2016 |
| Metformin use and risk of lactic acidosis in people with diabetes with and without renal impairment: a cohort study in Denmark and the UK L Li, S Jick, C Gopalakrishnan, U Heide‐Jørgensen, H Nørrelund, ... Diabetic Medicine 34 (4), 485-489, 2017 | 31 | 2017 |
| Comparative cardiovascular safety of glucagon‐like peptide‐1 receptor agonists versus other antidiabetic drugs in routine care: a cohort study E Patorno, BM Everett, AB Goldfine, RJ Glynn, J Liu, C Gopalakrishnan, ... Diabetes, Obesity and Metabolism 18 (8), 755-765, 2016 | 31 | 2016 |
| Rationale and design of the Study of a Tele-pharmacy Intervention for Chronic diseases to Improve Treatment adherence (STIC2IT): A cluster-randomized pragmatic trial NK Choudhry, T Isaac, JC Lauffenburger, C Gopalakrishnan, NF Khan, ... American heart journal 180, 90-97, 2016 | 30 | 2016 |
| The relative benefits of claims and electronic health record data for predicting medication adherence trajectory JM Franklin, C Gopalakrishnan, AA Krumme, K Singh, JR Rogers, ... American heart journal 197, 153-162, 2018 | 29 | 2018 |
| Comparative risk of harm associated with the use of targeted immunomodulators: a systematic review RJ Desai, KJ Thaler, P Mahlknecht, G Gartlehner, MS McDonagh, ... Arthritis Care & Research 68 (8), 1078-1088, 2016 | 28 | 2016 |
| Prevalence and impact of having multiple barriers to medication adherence in nonadherent patients with poorly controlled cardiometabolic disease JC Lauffenburger, T Isaac, R Bhattacharya, TD Sequist, ... The American journal of cardiology 125 (3), 376-382, 2020 | 24 | 2020 |
| Association of type of oral anticoagulant dispensed with adverse clinical outcomes in patients extending anticoagulation therapy beyond 90 days after hospitalization for venous … A Pawar, JJ Gagne, C Gopalakrishnan, G Iyer, H Tesfaye, G Brill, K Chin, ... Jama 327 (11), 1051-1060, 2022 | 18 | 2022 |
| Safety and effectiveness of dabigatran and other direct oral anticoagulants compared with warfarin in patients with atrial fibrillation KF Huybrechts, C Gopalakrishnan, DB Bartels, K Zint, VK Gurusamy, ... Clinical Pharmacology & Therapeutics 107 (6), 1405-1419, 2020 | 15 | 2020 |
| Evaluation of socioeconomic status indicators for confounding adjustment in observational studies of medication use C Gopalakrishnan, JJ Gagne, A Sarpatwari, SZ Dejene, SK Dutcher, ... Clinical Pharmacology & Therapeutics 105 (6), 1513-1521, 2019 | 15 | 2019 |
| Comparison of a new 3-item self-reported measure of adherence to medication with pharmacy claims data in patients with cardiometabolic disease JC Lauffenburger, CP Fontanet, T Isaac, C Gopalakrishnan, TD Sequist, ... American heart journal 228, 36-43, 2020 | 14 | 2020 |
| Claims data studies of direct oral anticoagulants can achieve balance in important clinical parameters only observable in electronic health records KF Huybrechts, C Gopalakrishnan, JM Franklin, K Zint, LR Franca, ... Clinical Pharmacology & Therapeutics 105 (4), 979-993, 2019 | 14 | 2019 |
| Evaluating utilization patterns of oral anticoagulants in routine care C Gopalakrishnan, S Schneeweiss, DB Bartels, K Zint, A Santiago Ortiz, ... Journal of Thrombosis and Haemostasis, 2019 | 12 | 2019 |
| Sequential monitoring of the comparative effectiveness and safety of dabigatran in routine care S Schneeweiss, C Gopalakrishnan, DB Bartels, JM Franklin, K Zint, ... Circulation: Cardiovascular Quality and Outcomes 12 (2), e005173, 2019 | 11 | 2019 |
| Empagliflozin and the risk of heart failure hospitalization in routine clinical care: a first analysis from the empagliflozin comparative effectiveness and safety (EMPRISE) study E Patorno, A Pawar, J Franklin, M Najafzadeh, A Déruaz-Luyet, ... Proceedings of the American Heart Association Scientific Sessions, 10-12, 2018 | 9 | 2018 |
Sebastian Schneeweiss, M.D., Sc.D.Professor of Medicine and Epidemiology, Harvard Medical School在 post.harvard.edu 的电子邮件经过验证
